艾德生物：高度重视对投资者的合理回报

Core Viewpoint - The company, Aide Biotechnology (艾德生物), emphasizes its commitment to reasonable returns for investors and maintains a prudent profit distribution policy, with future dividend plans to be determined by the board based on various factors [2]. Group 1: Investor Relations - The company acknowledges the importance of investor feedback regarding dividend policies and expresses appreciation for suggestions [2]. - Future dividend proposals will be evaluated by the board considering the company's development stage, actual operating performance, future funding needs, and relevant regulatory requirements [2].